Interestingly, we found an older median age of symptom onset of 16 years (range 8–24 years) and a lower rate of CKD progression in patients with NPHP4 mutations compared to patients with other gene defects, corroborating the findings of König et al. [6]. Here, NPHP4 is linked to chronic kidney disease.